Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Regenerative Signalling and the Limits of Repair: Full Evidence Review

Previous related pageVitamin D, Regenerative Signalling and the Limits of Repair: Study SummaryNext related pageVitamin D, Regenerative Signalling and the Limits of Repair: Study Summary
Study at a glance

How was vitamin D studied in tissue repair and bone healing?

This review examines vitamin D-related compounds in cell development, wound repair and fracture healing. It includes skin, dental and muscle-cell experiments, animal injury models and human fracture trials. A change in a growth-related marker is different from rebuilding tissue that works normally.

Did vitamin D compounds always improve tissue repair in experiments?

Selected exposures improved mouse wound closure or measurements of cell development, but effects depended on the compound, dose and cell state. The highest wound-treatment dose was not the best. In one mouse fracture model, early active-vitamin-D treatment impaired healing despite an immune-cell pattern that appeared to show less inflammation. Another substance made when the body processes vitamin D supported repair in separate mouse experiments, and active vitamin D did not substitute for it.

Did vitamin D help broken bones heal in people?

Results were mixed. Vita-Shock did not show clear benefits in its planned fracture-healing comparisons; a later analysis that explored the results further was not firm proof of benefit. A small wrist-fracture trial found unfavourable changes in some measurements made using scans at the higher dose, while other outcomes were unchanged. A separate, less reliable report found faster average joining of the broken bone with one treatment schedule, but compared two vitamin D treatment schedules rather than vitamin D with none.

Do these studies identify a way to speed healing with vitamin D?

The studies differed in age, fracture type, starting vitamin D, how and when treatment was given. Small samples and measurement or design limitations weaken broad conclusions. Cell markers do not establish a repaired tooth or muscle, and applying the active hormone directly to a particular area is not ordinary supplementation. The evidence does not show that vitamin D universally speeds tissue renewal, identify the best treatment schedule or establish general supplement harm.

Read the full article below ↓

Vitamin D-related compounds can influence signals associated with tissue regeneration, but favourable cell markers are not the same as restored tissue function. The evidence includes epidermal and dental progenitor models, muscle-cell experiments and fracture studies. Together, they show that cell state, metabolite identity and injury timing can change the response. Human fracture trials add positive, null and potentially adverse findings, preventing a simple claim that vitamin D universally accelerates regeneration. Vitamin D, Regenerative Signalling and the Limits of Repair: Study Summary.

Regenerative signalling and progenitor-cell activity

Regeneration requires more than increasing cell numbers. Cells must survive, proliferate when appropriate, acquire useful functions and organise into a working tissue. A marker of proliferation can support one part of that sequence without proving the rest. This distinction is central to Vitamin D and Regeneration and to interpreting experiments that describe stem or progenitor cells.

Vitamin D3, 25-hydroxyvitamin D and calcitriol are also different exposures. Direct application of active hormone to cultured cells or near an animal wound does not reproduce oral supplementation in a person. Concentration, local metabolism and the timing of exposure can all affect the result. The selected studies investigate particular interventions rather than one interchangeable “vitamin D effect”.

Epidermal cells and wound re-epithelialisation

Yan and colleagues studied skin wounds in young male mice and neonatal epidermal cells. The animal experiments used six mice per group, with two wounds averaged within each mouse. Those two wounds should not be counted as independent animals. The investigators tested calcitriol doses of 5, 50 and 250 nanograms delivered by subcutaneous injections around the wound.

The route matters because some wording in the paper suggests topical treatment. The methods describe peri-wound injection, so the findings should not be presented as a test of a vitamin D cream. The intermediate dose produced the strongest closure and re-epithelialisation signal. The lowest dose did not significantly improve closure, while the highest was less effective than the intermediate exposure. This pattern does not support “more is better”.

Cell proliferation and differentiation-associated measurements, together with a PI3K inhibitor, supported involvement of regenerative signalling. They did not provide lineage tracing showing which cells generated the repaired tissue. CCK8 measures metabolic activity, while PCNA is a proliferation-associated protein. These measurements and changes in cell markers are useful but limited observations; they cannot establish that a defined stem-cell population rebuilt functional human skin.

The inhibitor experiment also lacked genetic rescue. It supports pathway involvement while leaving room for additional actions of the intervention. A low-dose K14 comparison was not statistically significant. The study therefore supplies a preclinical signal with dose and measurement boundaries, not a comprehensive safety assessment or a human wound-treatment regimen. It informs the relationship between regeneration and Vitamin D and Tissue Repair without making those outcomes identical.

Dental pulp cells under inflammatory stress

Song and colleagues used commercially obtained human dental pulp stem cells. The cells received calcitriol pretreatment before lipopolysaccharide exposure, with later alkaline-phosphatase measurements used to assess a differentiation-associated response. Human-origin cells are valuable for studying cellular mechanisms, but a commercial culture is not a clinical trial and does not capture the diversity of patients.

At selected higher exposures, calcitriol reduced IL8 and COX2-related inflammatory readouts and restored alkaline-phosphatase-associated differentiation. IL1beta protein did not show the same significant response. This mixed pattern matters: the treatment did not uniformly suppress every inflammatory endpoint. ERK and JNK inhibitor experiments suggested pathway involvement, but pharmacological inhibitors do not provide perfectly specific causal tests.

The study did not measure actual mineral deposition, a repaired tooth or long-term tissue function. MTT is a metabolic assay and should not be treated as a direct count of proliferation. Donor numbers were not stated, experiments were small, and multiple comparisons were made. There was no genetic test establishing receptor dependence. These limitations place the findings within Vitamin D and Cell Differentiation, while leaving clinical regeneration unproved.

Taken together, the epidermal and dental studies support effects on progenitor-associated signalling in two different settings. They do not independently confirm one identical mechanism. One includes animal wound outcomes; the other concerns cultured cells under an inflammatory stimulus. Their complementary value lies in showing where a regenerative hypothesis has experimental support and where the chain to functional recovery remains incomplete.

Physiological enablers and limits of regeneration

The second question is why a potentially useful signal might fail to improve repair, or even become unfavourable under another condition. The remaining studies examine cell state, vitamin D metabolite identity, inflammatory timing and the distance between animal mechanisms and human outcomes. These are substantive biological constraints rather than reasons to dismiss all mechanistic work.

Fibroblast responses depend on the surrounding signal

Srikuea and colleagues examined primary skeletal-muscle fibroblasts from juvenile male mice. With 100 nanomolar calcitriol under basal conditions, incorporation of BrdU, a label used to track DNA synthesis, fell. When TGF-beta1 was present, that antiproliferative response was lost, while selected antifibrotic responses persisted, alongside changes involving Smad proteins, which mediate TGF-beta signals. Receptor knockdown also altered the response.

This is a direct demonstration that the surrounding signalling environment can change what calcitriol does to a cell. Reduced proliferation in an unstimulated culture does not predict the same result in an activated repair environment. Nor is less fibroblast activity automatically better: structural repair requires extracellular material as well as control of excessive deposition. The experiment did not include an injured animal or a human healing outcome.

Watcharanapapan and colleagues extended the context question in C2C12 muscle cells, comparing vitamin D3, 25-hydroxyvitamin D and calcitriol across concentrations and stages of differentiation. The metabolites produced different responses. Calcitriol suppressed BrdU and early myosin-heavy-chain measures, whereas vitamin D3 improved selected myogenic measurements. Fibrogenic markers also varied, and protein synthesis was not rescued in the relevant stress setting.

These findings prevent the compounds from being treated as equivalent. They also show why an antifibrotic marker is not a complete regeneration endpoint. Residual effects after receptor silencing do not prove absolute receptor independence, because knockdown need not remove every receptor-mediated influence. Proteomic associations did not establish an AMPK mechanism through direct causal intervention.

The two muscle papers came from the same research programme. They supply complementary cell types and experiments, not independent laboratory replication. Their relevance to Vitamin D and Protein Metabolism is that the balance between making, organising and degrading tissue components matters; a favourable marker in one part of that balance cannot establish restoration of the whole muscle.

Inflammation can be needed early in repair

Wasnik and colleagues studied fractures in vitamin-D-sufficient male mice. Local calcitriol shifted macrophage-associated markers away from an M1 pattern and toward an M2 pattern. When treatment began early, callus and union measures were impaired. A marker shift often described as anti-inflammatory therefore did not produce better structural repair in this setting.

Starting treatment on day ten did not significantly accelerate or impair the overall healing outcomes, although trabecular number increased. It would be inaccurate to say every late-treatment endpoint was null. The comparison instead suggests that the timing of the intervention affects its biological consequences. Vitamin D and Inflammatory Signalling is relevant because early immune activity can help initiate processes needed for later recovery.

The study does not prove that macrophages alone mediated the impaired healing. Groups were small, randomisation and blinding were not reported, and no macrophage-specific receptor knockout or mediation rescue isolated that route. Direct effects on mesenchymal cells remained possible. Local calcitriol in sufficient mice is also not equivalent to oral vitamin D3 in a deficient patient. The result constrains a universal regeneration claim without establishing general supplement harm.

A distinct vitamin D metabolite in fracture repair

Martineau and colleagues investigated 24R,25-dihydroxyvitamin D3, a metabolite often overshadowed by calcitriol. Their 2018 study used Cyp24a1-null survivor mice and chondrocyte-specific Fam57b deletion, together with rescue experiments. The findings supported a route involving 24R,25-dihydroxyvitamin D3, FAM57B2 and lactosylceramide in endochondral fracture repair.

Calcitriol did not substitute for the relevant rescue, while lactosylceramide acted downstream in the knockout setting. This distinction argues against assuming that every vitamin D-related repair effect is simply more active-hormone signalling through the familiar pathway. Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1) provides useful background on why changing metabolism can alter more than one compound.

The defect was transient, with later catch-up rather than permanent failure of repair. Cyp24a1-null survivors also have a complicated systemic metabolite environment, so their phenotype cannot be attributed to one isolated local change without qualification. Small groups, supraphysiological rescue and uncertainty about the local source of the metabolite limit translation. The study did not directly test receptor independence through a VDR knockout.

A 2020 follow-up from the same programme treated wild-type female mice after tibial osteotomy with subcutaneous 24R,25-dihydroxyvitamin D3 or lactosylceramide beginning on day three. Selected stiffness and modulus outcomes improved, particularly around day eighteen. Effects varied by compound and time, and not every mechanical measure improved. This extended the programme beyond genetic rescue but did not provide independent laboratory confirmation.

Small endpoint-specific groups, limited histology, no reported randomisation or blinding and a short serum-chemistry safety assessment constrain the result. Expression timing alone did not experimentally establish the best treatment window. A patent-inventor conflict was disclosed. The work supports a preclinical repair mechanism, not human efficacy or long-term safety. It belongs within Vitamin D and Bone, with the animal and metabolite boundaries kept explicit.

Human fracture outcomes remain mixed

The Vita-Shock phase II trial enrolled 102 adults aged eighteen to fifty with surgically fixed tibial or femoral fractures. The four arms were 150,000 IU at injury and again at six weeks, 4,000 IU daily, 600 IU daily, or placebo; daily treatment lasted three months. These were trial regimens, not recommendations. Its prespecified comparisons on clinical Function IndeX for Trauma (FIX-IT) and Radiographic Union Score for Tibial fractures (RUST) outcomes were null. A post hoc high-dose clinical signal used 80% confidence intervals and p values around 0.16 and 0.18, so it was exploratory rather than conventional confirmatory evidence of benefit. Adherence, attrition and small groups also limited precision.

Heyer and colleagues studied postmenopausal women with conservatively treated distal-radius fractures. Thirty-two were randomised and thirty completed. Two bolus-dose regimens used 30,000 or 75,000 IU at the first and third visits, six weeks apart, and were compared with no supplementation over twelve weeks. The higher regimen showed adverse changes in selected trabecular and estimated compression measurements, while several other outcomes and patient-rated wrist results were null. These were imaging-derived mechanical estimates, not direct tests of bone failure strength.

That study lacked a placebo and had baseline imbalances, replacement participants and multiple comparisons. It does not establish that ordinary daily vitamin D harms fracture repair. It does show why one cannot presume that a higher dose improves all aspects of regeneration, particularly when the population and delivery pattern differ from other trials.

Selvaraj and colleagues provide a positive counterexample with important weaknesses. Fifty adults with mixed long-bone fractures and low vitamin D were assigned to 1,000 IU daily or 60,000 IU weekly for twelve weeks, both with calcium. Reported mean union times were 18.6 and 15.9 weeks, respectively, with p=0.002. At twenty-four weeks, union proportions of 84% and 96% did not differ significantly, and one hypercalcaemia event occurred in the weekly group.

This comparison did not include vitamin D versus none. Frequency was confounded by a large difference in total dose. Concealment and blinding were unclear, registry and recruitment details were missing, and the ascertainment of union timing between scheduled visits was insufficiently explained. The result should be retained as a low-confidence positive report, not upgraded into an optimal-regimen recommendation.

What regeneration claims would require

The trials differ in age, fracture type, baseline status, fixation, exposure and outcome. Their results cannot be reduced to a vote for or against vitamin D. A rise in serum concentration does not itself prove functional regeneration, a distinction developed in Vitamin D Status vs Vitamin D Effect. Similarly, none of these experiments demonstrates reversal of the persistent cell states discussed in Vitamin D and Cellular Senescence.

The selected evidence supports several possible enablers of repair, but also shows limits at every level: marker versus function, local hormone versus nutritional exposure, early versus late inflammation, and animal mechanism versus clinical outcome. Mitochondrial activity is another component of a functioning cell, discussed in Vitamin D and Mitochondrial Function; it was not directly established as the mediator of regeneration in these studies.

Conclusion

Vitamin D-related compounds influence progenitor-associated signalling and repair biology in experimental models. Their effects depend on cell state, metabolite and timing, and favourable markers do not guarantee functional regeneration. Mixed human fracture findings leave clinical benefit uncertain. The evidence supports careful, model-specific explanations rather than a universal claim that vitamin D accelerates tissue renewal.

Original research

Yan R et al. 2025. 1α,25-Dihydroxyvitamin D3 accelerates skin wound re-epithelialization by promoting epidermal stem cell proliferation and differentiation through PI3K activation: an in vitro and in vivo study. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 58: e14121. DOI: 10.1590/1414-431x2025e14121. PMID: 40053036.

Srikuea R et al. 2023. TGF-β1 stimulation and VDR-dependent activation modulate calcitriol action on skeletal muscle fibroblasts and Smad signalling-associated fibrogenesis. Scientific reports. 13(1): 13811. DOI: 10.1038/s41598-023-40978-w. PMID: 37612333.

Watcharanapapan W et al. 2025. Regulatory role of vitamin D3 on myogenesis and fibrogenesis under Vdr gene silencing and TGF-β1 stimulation in skeletal muscle cells. Scientific reports. 15(1): 41599. DOI: 10.1038/s41598-025-25496-1. PMID: 41286086.

Song SE et al. 2026. Dual effects of 1α,25-dihydroxyvitamin D3 on inflammation and osteogenic differentiation in lipopolysaccharide-stimulated dental pulp stem cells. Journal of dental sciences. 21(3): 1948-1957. DOI: 10.1016/j.jds.2025.07.3564. PMID: 42689044.

Wasnik S et al. 2018. 1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites. JCI insight. 3(17): e98773. DOI: 10.1172/jci.insight.98773. PMID: 30185660.

Slobogean GP et al. 2023. Effect of Vitamin D3 Supplementation on Acute Fracture Healing: A Phase II Screening Randomized Double-Blind Controlled Trial. JBMR plus. 7(1): e10705. DOI: 10.1002/jbm4.10705. PMID: 36699638.

Heyer FL et al. 2021. The Effect of Bolus Vitamin D3 Supplementation on Distal Radius Fracture Healing: A Randomized Controlled Trial Using HR-pQCT. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 36(8): 1492. DOI: 10.1002/jbmr.4311. PMID: 33877707.

Selvaraj NV et al. 2026. Effect of Vitamin D Supplementation Regimens on Fracture Healing and Serum Biomarker Profile in Long-Bone Fractures: A Prospective Randomized Study. Journal of orthopaedic case reports. 16(5): 401-409. DOI: 10.13107/jocr.2026.v16.i05.7314. PMID: 42130995.

Martineau C et al. 2018. Optimal bone fracture repair requires 24R,25-dihydroxyvitamin D3 and its effector molecule FAM57B2. The Journal of clinical investigation. 128(8). DOI: 10.1172/jci98093. PMID: 30010626.

Martineau C et al. 2020. Preclinical safety and efficacy of 24R,25-dihydroxyvitamin D3 or lactosylceramide treatment to enhance fracture repair. Journal of orthopaedic translation. 23: 77-88. DOI: 10.1016/j.jot.2020.03.013. PMID: 32518749.

Related reading

Physiology

Vitamin D and Tissue Repair

Explore how vitamin D participates in tissue repair through immune coordination, cellular differentiation, vascular support, and long-term physiological integration.

Read more →
Physiology

Vitamin D and Regeneration

Explore how vitamin D participates in cellular regeneration, stem-cell activity, immune coordination, and long-term tissue renewal as part of whole-system physiological regulation.

Read more →

Original sources

Source

1α,25-Dihydroxyvitamin D3 accelerates skin wound re-epithelialization by promoting epidermal stem cell proliferation and differentiation through PI3K activation: an in vitro and in vivo study

Yan R et al. 2025. 1α,25-Dihydroxyvitamin D3 accelerates skin wound re-epithelialization by promoting epidermal stem cell proliferation and differentiation through PI3K activation: an in vitro and in vivo study.

Publication details

Yan R et al. 2025. 1α,25-Dihydroxyvitamin D3 accelerates skin wound re-epithelialization by promoting epidermal stem cell proliferation and differentiation through PI3K activation: an in vitro and in vivo study. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 58: e14121. DOI: 10.1590/1414-431x2025e14121. PMID: 40053036.

Read more →
Source

TGF-β1 stimulation and VDR-dependent activation modulate calcitriol action on skeletal muscle fibroblasts and Smad signalling-associated fibrogenesis

Herein, the effects of calcitriol on cultured skeletal muscle primary fibroblasts of male C57BL/6 mice (aged 1 month old) were investigated.

Publication details

Srikuea R et al. 2023. TGF-β1 stimulation and VDR-dependent activation modulate calcitriol action on skeletal muscle fibroblasts and Smad signalling-associated fibrogenesis. Scientific reports. 13(1): 13811. DOI: 10.1038/s41598-023-40978-w. PMID: 37612333.

Read more →
Source

Dual effects of 1α,25-dihydroxyvitamin D3 on inflammation and osteogenic differentiation in lipopolysaccharide-stimulated dental pulp stem cells

Published in Journal of dental sciences. 21(3): 1948-1957. DOI: 10.1016/j.jds (2025).

Publication details

Song SE et al. 2026. Dual effects of 1α,25-dihydroxyvitamin D3 on inflammation and osteogenic differentiation in lipopolysaccharide-stimulated dental pulp stem cells. Journal of dental sciences. 21(3): 1948-1957. DOI: 10.1016/j.jds.2025.07.3564. PMID: 42689044.

Read more →
Source

Effect of Vitamin D Supplementation Regimens on Fracture Healing and Serum Biomarker Profile in Long-Bone Fractures: A Prospective Randomized Study

Published in Journal of orthopaedic case reports. 16(5): 401-409. DOI: 10.13107/jocr (2026).

Publication details

Selvaraj NV et al. 2026. Effect of Vitamin D Supplementation Regimens on Fracture Healing and Serum Biomarker Profile in Long-Bone Fractures: A Prospective Randomized Study. Journal of orthopaedic case reports. 16(5): 401-409. DOI: 10.13107/jocr.2026.v16.i05.7314. PMID: 42130995.

Read more →